Atlas FDA

Cordis Exoseal Vascular Closure Device

FDA premarket approval P100013/S015 · decided 2017-12-14

Approval details

PMA number
P100013
Supplement
S015
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Cordis Exoseal Vascular Closure Device
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2017-08-11
Decision date
2017-12-14
Days to decision
125 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
Approval to add Steri-Tek as a new E-beam sterilization site for the Exoseal Vascular Closure Device.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.